Amundi »

Janux Therapeutics shares owned by Amundi

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Amundi from 13F filings

Historical chart of Amundi investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Amundi consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Amundi

Quarter filed Position value Share count Share price at filing
2024-09-30 $376k 8.4k 44.93

More positions owned by Amundi

Apple (AAPL)
Amazon Commstck (AMZN)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Tesla Motors (TSLA)
Exxon Mobil Corporation (XOM)
Home Depot (HD)
Advanced Micro Devices Commstck (AMD)
Berkshire Hathaway Cl B New (BRK.B)
Adobe Systems Incorporated (ADBE)
Mastercard Cl A (MA)
Visa Com Cl A (V)

View all positions for Amundi

Top funds holding Janux Therapeutics

RA Capital Management
BlackRock
Paradigm Biocapital Advisors
BlackRock
Henderson Group
Woodline Partners
Vanguard Group
EcoR1 Capital
State Street Corporation
OrbiMed Advisors
Citadel Advisors
Cormorant Asset Management
Logos Global Management
Lord, Abbett & Co
Geode Capital Management

View all funds holding Janux Therapeutics